Literature DB >> 18770099

Screening instruments for older adult depressive disorders: updating the evidence-based toolbox.

Marian W Roman1, Bonnie L Callen.   

Abstract

The prevalence of clinically significant depressive disorders in persons 65 years of age or older in the United States has been estimated to be approximately 15%, increasing the risk for functional decline, morbidity, and mortality. Utilization of a well-chosen screening instrument has been shown to improve the rates of recognition of depressive disorders in older adults. This paper presents a targeted review of the most commonly accepted tools for case-finding of depressive disorders in older adults. After a review of the benefits and shortcomings of screening tools, the strengths, weaknesses, and utility of selected depression scales in geriatric clinical settings are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18770099     DOI: 10.1080/01612840802274578

Source DB:  PubMed          Journal:  Issues Ment Health Nurs        ISSN: 0161-2840            Impact factor:   1.835


  3 in total

1.  Urban environment, physical inactivity and unhealthy dietary habits correlate to depression among elderly living in eastern Mediterranean islands: the MEDIS (MEDiterranean ISlands Elderly) study.

Authors:  E Mamplekou; V Bountziouka; T Psaltopoulou; A Zeimbekis; N Tsakoundakis; N Papaerakleous; E Gotsis; G Metallinos; G Pounis; E Polychronopoulos; C Lionis; D Panagiotakos
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

2.  Depression as a correlate of functional status of community-dwelling older adults: utilizing a short-version of 5-item Geriatric Depression Scale as a screening tool.

Authors:  H J Song; K Meade; U Akobundu; N R Sahyoun
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

3.  A prospective cohort study to examine the association between dietary patterns and depressive symptoms in older Chinese people in Hong Kong.

Authors:  Ruth Chan; Dicken Chan; Jean Woo
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.